scholarly article | Q13442814 |
P356 | DOI | 10.18632/AGING.100567 |
P8608 | Fatcat ID | release_plwyrcovrjbotgvlm6vuhlv67i |
P932 | PMC publication ID | 3824410 |
P698 | PubMed publication ID | 23793615 |
P50 | author | Baziel van Engelen | Q110544835 |
Seyed Yahya Anvar | Q114417603 | ||
Andrea Venema | Q117249159 | ||
Barbara van der Sluijs | Q130279306 | ||
Nisha Verway | Q130279323 | ||
Jelle J Goeman | Q48799316 | ||
Yotam Raz | Q56252230 | ||
Peter A.C. 't Hoen | Q57190543 | ||
Silvère M van der Maarel | Q59661580 | ||
Vered Raz | Q87734521 | ||
John Vissing | Q90104169 | ||
P2860 | cites work | Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy | Q24308826 |
The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored | Q24607390 | ||
Linear models and empirical bayes methods for assessing differential expression in microarray experiments | Q27860758 | ||
Nuclear inclusions in oculopharyngeal muscular dystrophy consist of poly(A) binding protein 2 aggregates which sequester poly(A) RNA | Q28139419 | ||
Oculopharyngeal muscular dystrophy: a polyalanine myopathy | Q28303935 | ||
Oculopharyngeal muscular dystrophy-like nuclear inclusions are present in normal magnocellular neurosecretory neurons of the hypothalamus | Q28570226 | ||
Impairment of the ubiquitin-proteasome system by protein aggregation | Q29614556 | ||
Literature-aided meta-analysis of microarray data: a compendium study on muscle development and disease | Q31160383 | ||
Loss of nuclear poly(A)-binding protein 1 causes defects in myogenesis and mRNA biogenesis. | Q33697689 | ||
Molecular and phenotypic characterization of a mouse model of oculopharyngeal muscular dystrophy reveals severe muscular atrophy restricted to fast glycolytic fibres | Q34102486 | ||
Fat tissue, aging, and cellular senescence | Q34130783 | ||
Oxidative damage and mitochondrial decay in aging | Q34326443 | ||
Doxycycline attenuates and delays toxicity of the oculopharyngeal muscular dystrophy mutation in transgenic mice | Q34415166 | ||
A Drosophila model of oculopharyngeal muscular dystrophy reveals intrinsic toxicity of PABPN1. | Q34518248 | ||
Nuclear and chromatin reorganization during cell senescence and aging - a mini-review | Q34540621 | ||
Polyglutamine diseases: emerging concepts in pathogenesis and therapy | Q34696955 | ||
Pre-mRNA splicing modulations in senescence. | Q35185569 | ||
Analysis of alternative splicing associated with aging and neurodegeneration in the human brain. | Q35451664 | ||
Progressive myopathy in an inducible mouse model of oculopharyngeal muscular dystrophy | Q35577123 | ||
Nile red: a selective fluorescent stain for intracellular lipid droplets | Q36211849 | ||
Opinion: What is the role of protein aggregation in neurodegeneration? | Q36259086 | ||
Poly(A) binding protein nuclear 1 levels affect alternative polyadenylation | Q36305636 | ||
Anni 2.0: a multipurpose text-mining tool for the life sciences | Q36787149 | ||
The Human Ageing Genomic Resources: online databases and tools for biogerontologists. | Q37318261 | ||
Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate-forming lipophilic cation JC-1. | Q37494492 | ||
Amyloid in neurodegenerative diseases: friend or foe? | Q37860535 | ||
The ubiquitin proteasome system in neurodegenerative diseases: culprit, accomplice or victim? | Q37978123 | ||
Review: quantifying mitochondrial dysfunction in complex diseases of aging. | Q37998247 | ||
Gene expression profile of aging in human muscle | Q38353969 | ||
A global test for groups of genes: testing association with a clinical outcome | Q38522319 | ||
Modeling oculopharyngeal muscular dystrophy in myotube cultures reveals reduced accumulation of soluble mutant PABPN1 protein | Q38575523 | ||
PABPN1 shuts down alternative poly(A) sites | Q39340896 | ||
The poly(A)-binding protein nuclear 1 suppresses alternative cleavage and polyadenylation sites. | Q39364902 | ||
Reversible aggregation of PABPN1 pre-inclusion structures | Q39494752 | ||
Cellular senescence in human myoblasts is overcome by human telomerase reverse transcriptase and cyclin-dependent kinase 4: consequences in aging muscle and therapeutic strategies for muscular dystrophies | Q40121913 | ||
Poly(A) tail length is controlled by the nuclear poly(A)-binding protein regulating the interaction between poly(A) polymerase and the cleavage and polyadenylation specificity factor | Q41806905 | ||
Deregulation of the ubiquitin-proteasome system is the predominant molecular pathology in OPMD animal models and patients | Q42868694 | ||
Sirtuin inhibition protects from the polyalanine muscular dystrophy protein PABPN1. | Q46656918 | ||
Human muscle aging: ROS-mediated alterations in rectus abdominis and vastus lateralis muscles. | Q46742968 | ||
Wild-type PABPN1 is anti-apoptotic and reduces toxicity of the oculopharyngeal muscular dystrophy mutation. | Q46820379 | ||
Oculopharyngeal muscular dystrophy with limb girdle weakness as major complaint | Q47348943 | ||
Skeletal muscle gene expression profiles in 20-29 year old and 65-71 year old women | Q47908413 | ||
Changes in lamina structure are followed by spatial reorganization of heterochromatic regions in caspase-8-activated human mesenchymal stem cells. | Q50714075 | ||
Extracting biological meaning from large gene lists with DAVID. | Q51795802 | ||
Expression of the polyalanine expansion mutant of nuclear poly(A)-binding protein induces apoptosis via the p53 pathway. | Q53173112 | ||
Prevention of oculopharyngeal muscular dystrophy-associated aggregation of nuclear poly(A)-binding protein with a single-domain intracellular antibody | Q60297063 | ||
Nuclear inclusions in oculopharyngeal dystrophy | Q72843808 | ||
P4510 | describes a project that uses | limma | Q112236343 |
P433 | issue | 6 | |
P921 | main subject | muscle weakness | Q270421 |
P304 | page(s) | 412-426 | |
P577 | publication date | 2013-06-01 | |
P1433 | published in | Aging | Q2845875 |
P1476 | title | A decline in PABPN1 induces progressive muscle weakness in oculopharyngeal muscle dystrophy and in muscle aging | |
P478 | volume | 5 |
Q85822831 | Ageing and muscular dystrophy differentially affect murine pharyngeal muscles in a region-dependent manner |
Q42243485 | An alanine expanded PABPN1 causes increased utilization of intronic polyadenylation sites |
Q40570752 | Blood RNA expression profiles undergo major changes during the seventh decade |
Q37428337 | Control of mRNA stability contributes to low levels of nuclear poly(A) binding protein 1 (PABPN1) in skeletal muscle |
Q40629006 | Cytokine genes as potential biomarkers for muscle weakness in OPMD. |
Q100737078 | Cytoskeletal disorganization underlies PABPN1-mediated myogenic disability |
Q64236077 | Deacetylation Inhibition Reverses PABPN1-Dependent Muscle Wasting |
Q89146104 | Deregulation of RNA Metabolism in Microsatellite Expansion Diseases |
Q64895891 | Diagnostics of short tandem repeat expansion variants using massively parallel sequencing and componential tools. |
Q42907623 | Dysfunctional transcripts are formed by alternative polyadenylation in OPMD. |
Q48112558 | Functional impact of an oculopharyngeal muscular dystrophy mutation in PABPN1. |
Q91843569 | Inhibition of myostatin improves muscle atrophy in oculopharyngeal muscular dystrophy (OPMD) |
Q35093811 | Major aging-associated RNA expressions change at two distinct age-positions. |
Q90733720 | Mouse models for muscular dystrophies: an overview |
Q50962265 | Novel mouse models of oculopharyngeal muscular dystrophy (OPMD) reveal early onset mitochondrial defects and suggest loss of PABPN1 may contribute to pathology. |
Q37507541 | Nuclear poly(A)-binding protein aggregates misplace a pre-mRNA outside of SC35 speckle causing its abnormal splicing |
Q34449597 | Oculopharyngeal muscular dystrophy as a paradigm for muscle aging |
Q36010483 | PABPN1-Dependent mRNA Processing Induces Muscle Wasting. |
Q88004256 | Post-transcriptional regulation of gene expression and human disease |
Q45860522 | Proteasomal activity-based probes mark protein homeostasis in muscles |
Q38876359 | Regulated Intron Retention and Nuclear Pre-mRNA Decay Contribute to PABPN1 Autoregulation |
Search more.